PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 1,490.00
+29.00 (1.98%)
At close: Apr 24, 2026
PeopleBio Revenue
In the year 2025, PeopleBio had annual revenue of 2.85B KRW with 12.64% growth.
Revenue
2.85B
Revenue Growth
+12.64%
P/S Ratio
10.85
Revenue / Employee
61.97M
Employees
46
Market Cap
30.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.85B | 319.91M | 12.64% |
| Dec 31, 2024 | 2.53B | -1.92B | -43.17% |
| Dec 31, 2023 | 4.45B | 8.02M | 0.18% |
| Dec 31, 2022 | 4.44B | 3.87B | 670.22% |
| Dec 31, 2021 | 577.08M | 69.23M | 13.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Cross Medical Science | 108.41B |
| Seoulin Bioscience | 77.09B |
| Dx & Vx | 29.36B |
| Cytogen | 26.05B |
| Protia | 15.12B |
| HLB Panagene | 15.05B |
| 3billion | 11.71B |
| GENINUS | 10.48B |